Literature DB >> 11754305

Neurologic manifestations of connective tissue disease.

Stephen E Nadeau1.   

Abstract

The clinical features, diagnosis, and treatment of systemic lupus erythematosus, scleroderma, rheumatoid arthritis, Sjögren's syndrome, mixed connective tissue disease, Behcet's disease, Cogan's syndrome, and relapsing polychondritis are reviewed from a neurological perspective with an emphasis on pathogenic mechanisms and their relationship to treatment.

Entities:  

Mesh:

Year:  2002        PMID: 11754305     DOI: 10.1016/s0733-8619(03)00057-4

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  14 in total

1.  Detection of asymptomatic cranial neuropathies in patients with systemic lupus erythematosus and their relation to antiribosomal P antibody levels and disease activity.

Authors:  Wafaa Gaber; Yasser Ezzat; Neveen M El Fayoumy; Hanan Helmy; Abeer M Mohey
Journal:  Clin Rheumatol       Date:  2014-05-24       Impact factor: 2.980

2.  The effect of corticosteroid medication on quantitative MR parameters of the brain.

Authors:  Stefan C A Steens; Gerda M Steup-Beekman; Gerlof P Th Bosma; Faiza Admiraal-Behloul; Hans Olofsen; Joost Doornbos; Tom W J Huizinga; Mark A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

3.  Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports.

Authors:  Emily T Fain; Melissa Mannion; Elena Pope; Daniel W Young; Ronald M Laxer; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-29       Impact factor: 3.054

4.  Recurrent lower motor neuron type facial palsy: an unusual manifestation of SLE.

Authors:  Durgesh Kumar Gupta; Virendra Atam; S C Chaudhary
Journal:  BMJ Case Rep       Date:  2011-02-02

5.  Vascular neurobehcet disease: correlation with current disease activity forum and systemic vascular involvement.

Authors:  Reem H A Mohammed; Amr Nasef; Hanady H Kewan; Mohammed Al Shaar
Journal:  Clin Rheumatol       Date:  2012-03-14       Impact factor: 2.980

6.  Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis.

Authors:  Sherifa A Hamed; Zahra I Selim; Amal M Elattar; Yasser M Elserogy; Eman A Ahmed; Hanan O Mohamed
Journal:  Clin Rheumatol       Date:  2011-06-22       Impact factor: 2.980

7.  Antibody induction of lupus-like neuropsychiatric manifestations.

Authors:  David A Lawrence; Valerie J Bolivar; Chad A Hudson; Tapan K Mondal; Nina G Pabello
Journal:  J Neuroimmunol       Date:  2006-12-06       Impact factor: 3.478

8.  Longstanding epileptic encephalopathy and linear localized scleroderma: two distinct pathologic processes in an adolescent.

Authors:  Donato Rigante; Domenica Battaglia; Ilaria Contaldo; Ilaria La Torraca; Laura Avallone; Stefania Gaspari; Giulia Bersani; Achille Stabile
Journal:  Rheumatol Int       Date:  2008-02-16       Impact factor: 2.631

9.  Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus.

Authors:  Ahmed M Abdel-Nasser; Rasha M Ghaleb; Jehan A Mahmoud; Wafaa Khairy; Refaat M Mahmoud
Journal:  Clin Rheumatol       Date:  2008-05-15       Impact factor: 2.980

10.  Comparison of the clinical manifestations, brain MRI and prognosis between neuroBeçhet's disease and neuropsychiatric lupus.

Authors:  Byung-Sik Cho; Hyun-Sook Kim; Su-Jin Oh; Hyeok-Jae Koh; Chong-Hyun Yoon; So-Lyung Jung; Do-June Min; Wan-Uk Kim
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.